Evidence map›Paper›PMID 18086006›Full record

Trial reportJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2008

Regulation of bone turnover by sex steroids in men.

Arunik Sanyal, Kelley A Hoey, Ulrike I Mödder, Jesse L Lamsam, Louise K McCready, James M Peterson, Sara J Achenbach, Merry Jo Oursler, Sundeep Khosla

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Regulation of circulating sclerostin levels by sex steroids in women and in men.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2011
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Influence of aromatase inhibition on the bone-protective effects of testosterone.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2014
    Article
  13. Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Article
  14. Article
  15. Aging and bone loss: new insights for the clinician.Therapeutic advances in musculoskeletal disease · 2012
    Article
  16. Reproductive hormones and bone.Current osteoporosis reports · 2010
    Review
  17. Physiology of bone loss.Radiologic clinics of North America · 2010
    Review
  18. Pathogenesis of Osteoporosis.Translational endocrinology & metabolism · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Arunik SanyalEndocrine Research Unit, Division of Endocrinology and Metabolism, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Kelley A Hoey
Ulrike I Mödder
Jesse L Lamsam
Louise K McCready
James M Peterson
Sara J Achenbach
Merry Jo Oursler
Sundeep Khosla
Mayo Clinic · US

Funding

MAYO CLINIC CENTER FOR TRANSLATIONAL SCIENCE ACTIVITIESUL1RR024150 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 2006 to 2011
$66.4M
SEX STEROIDS, GROWTH FACTORS, &BONE CELL FUNCTIONP01AG004875 · NIA · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 1985 to 2019
$30.8M
NCRR NIH HHS 1UL1RR024150NCRR NIH HHS UL1 RR024150NIA NIH HHS P01 AG004875
6 · The paper itself

Abstract

introductionThe mechanism(s) by which sex steroids regulate bone turnover in humans are unclear, and recent studies have suggested that follicle-stimulating hormone (FSH) may play an important role in regulating bone resorption. MATERIALS AND

methodsFifty-nine men (median age, 69 yr) underwent suppression of sex steroids using a gonadotropin-releasing hormone (GnRH) agonist and aromatase blocker and were replaced with testosterone (T; 5 mg/d) and estradiol (E; 37.5 microg/d). After assessment of bone resorption markers (serum C-terminal telopeptide of type I collagen [CTX] and TRACP5b), they were randomized to sex steroid deficiency (-T, -E), E alone (-T, +E), T alone (+T, -E), or both (+T, +E) and restudied 3 wk later. Bone marrow aspirates were obtained to isolate osteoblastic, T, and monocytic cells using magnetic-activated cell sorting.

resultsSerum CTX and TRACP5b increased significantly (by 71% and 15%, p < 0.01 and < 0.001, respectively) in the -T, -E group, and these increases occurred despite a 60% suppression of serum FSH levels (p < 0.001) caused by the GnRH agonist. There were significant E (but not T) effects on preventing increases in serum CTx and TRACP levels. There was a nonsignificant trend (p = 0.122) for E to suppress RANKL mRNA levels in bone marrow osteoblastic cells. Changes in mRNA levels for other cytokines (TNF-alpha, interleukin (IL)-1alpha, IL-1beta, IL-1ra, IFN-gamma) in bone marrow cells were not significant.

conclusionsE has greater suppressive effects on bone resorption than T, and increased bone resorption after sex steroid deficiency can occur independently of changes in FSH secretion. E effects on bone resorption may be mediated by regulation of RANKL production by osteoblastic cells, although further studies using more highly purified cells may reduce the variability of the mRNA measurements and allow for clearer definition of the mediators of sex steroid action in vivo.

Indexed as

Bone RemodelingAgedAged, 80 and overEnzyme-Linked Immunosorbent AssayFlow CytometryFollicle Stimulating HormoneHumansMaleMiddle AgedRANK LigandRNA, MessengerFollicle Stimulating HormoneRANK LigandRNA, MessengerTNFSF11 protein, human

Identifiers

PMID18086006
PMCPMC2674543
OpenAlexW2037050680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.